| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $102.0M | +10.0% |
| Cost of Revenue | $44.1M | +10.4% |
| Gross Profit | $57.9M | +9.8% |
| R&D Expense | $13.9M | +14.7% |
| SG&A Expense | $23.9M | +16.2% |
| Operating Income | -$7.9M | -534.0% |
| Pre-tax Income | -$8.4M | -455.0% |
| Income Tax | $778K | -35.4% |
| Net Income | -$9.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.2M | +131.2% |
| Accounts Receivable | $19.6M | -20.1% |
| Current Assets | $43.5M | +8.0% |
| Total Assets | $136.8M | -1.4% |
| Current Liabilities | $56.1M | -6.3% |
| Total Liabilities | $64.4M | +0.7% |
| Stockholders' Equity | $72.4M | -3.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $22.2M | +102.9% |
| Capital Expenditures | $6.3M | +25.2% |
| Investing Cash Flow | -$6.4M | +61.0% |
| Financing Cash Flow | -$8.2M | -1137.4% |
| Free Cash Flow | $15.9M | +169.5% |
| -237.7% |
| EPS (Basic) | -$0.72 | -227.3% |
| EPS (Diluted) | -$0.72 | -227.3% |